Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors

ABSTRACT: NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors

PROVIDER: PRJNA317702 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

NHLBI TOPMed: Mayo Clinic Venous Thromboembolism (VTE) Study

Project description:NHLBI TOPMed: Mayo Clinic Venous Thromboembolism (VTE) Study

| PRJNA393376 | ENA

Homo sapiens

Project description:NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors

| PRJNA317703 | ENA

NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors

Project description:<p>We collected DNA from fresh frozen prostate tumor samples and matched peripheral blood from 10 subjects with aggressive, Gleason score ≥8 disease. Tumor and normal samples were sequenced on the Illumina HiSeq 2000 to mean depths of 95.3X and 48.3X, respectively.</p>

| phs001105 | dbGaP

mouse gut metagenome

Project description:Mayo Clinic Microbiota Project

| PRJNA529438 | ENA

NHGRI CLL WES Relapse Study

Project description:NHGRI CLL WES Relapse Study

| PRJNA277245 | ENA

NHGRI Large Scale Sequencing Program

Project description:NHGRI Large Scale Sequencing Program

| PRJNA158497 | ENA

NHGRI Mendelian Disorders Sequencing Centers

Project description:NHGRI Mendelian Disorders Sequencing Centers

| PRJNA158501 | ENA

PGRN-RIKEN Mayo Breast Cancer

Project description:PGRN-RIKEN Mayo Breast Cancer

| PRJNA75545 | ENA

NHGRI Menin ChIP-Chip

Project description:Multiple endocrine neoplasia type I (MEN1) is a familial cancer syndrome characterized primarily by tumors of multiple endocrine glands. The gene for MEN1 encodes a ubiquitously expressed tumor suppressor protein called menin. Menin was recently shown to interact with several components of a trithorax family histone methyltransferase complex including ASH2, Rbbp5, WDR5, and the leukemia proto-oncoprotein MLL. To elucidate menin's role as a tumor suppressor and gain insights into the endocrine-specific tumor phenotype in MEN1, we mapped the genomic binding sites of menin, MLL1, and Rbbp5, to approximately 20,000 promoters in HeLa S3, HepG2, and pancreatic islet cells using the strategy of chromatin-immunoprecipitation coupled with microarray analysis. We found that menin, MLL1, and Rbbp5 localize to the promoters of thousands of human genes but do not always bind together. These data suggest that menin functions as a general regulator of transcription. Keywords: ChIP/chip NHGRI Menin ChIP-Chip

2006-07-24 | E-GEOD-5357 | biostudies-arrayexpress

Mayo Clinic Zebrafish Facility Overview.

Project description: Not available

| S-EPMC4931757 | biostudies-literature